These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33788036)

  • 61. Olfactory Bulb Signal Abnormality in Patients with COVID-19 Who Present with Neurologic Symptoms.
    Strauss SB; Lantos JE; Heier LA; Shatzkes DR; Phillips CD
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1882-1887. PubMed ID: 32855190
    [TBL] [Abstract][Full Text] [Related]  

  • 62. More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis.
    Parma V; Ohla K; Veldhuizen MG; Niv MY; Kelly CE; Bakke AJ; Cooper KW; Bouysset C; Pirastu N; Dibattista M; Kaur R; Liuzza MT; Pepino MY; Schöpf V; Pereda-Loth V; Olsson SB; Gerkin RC; Rohlfs Domínguez P; Albayay J; Farruggia MC; Bhutani S; Fjaeldstad AW; Kumar R; Menini A; Bensafi M; Sandell M; Konstantinidis I; Di Pizio A; Genovese F; Öztürk L; Thomas-Danguin T; Frasnelli J; Boesveldt S; Saatci Ö; Saraiva LR; Lin C; Golebiowski J; Hwang LD; Ozdener MH; Guàrdia MD; Laudamiel C; Ritchie M; Havlícek J; Pierron D; Roura E; Navarro M; Nolden AA; Lim J; Whitcroft KL; Colquitt LR; Ferdenzi C; Brindha EV; Altundag A; Macchi A; Nunez-Parra A; Patel ZM; Fiorucci S; Philpott CM; Smith BC; Lundström JN; Mucignat C; Parker JK; van den Brink M; Schmuker M; Fischmeister FPS; Heinbockel T; Shields VDC; Faraji F; Santamaría E; Fredborg WEA; Morini G; Olofsson JK; Jalessi M; Karni N; D'Errico A; Alizadeh R; Pellegrino R; Meyer P; Huart C; Chen B; Soler GM; Alwashahi MK; Welge-Lüssen A; Freiherr J; de Groot JHB; Klein H; Okamoto M; Singh PB; Hsieh JW; ; Reed DR; Hummel T; Munger SD; Hayes JE
    Chem Senses; 2020 Oct; 45(7):609-622. PubMed ID: 32564071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anosmia caused by brain tumor.
    Li LJ; Chien-Yi L; Tsai CY; Wu CJ
    Am J Med Sci; 2023 Jan; 365(1):e12. PubMed ID: 36037987
    [No Abstract]   [Full Text] [Related]  

  • 64. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.
    Trachootham D; Thongyen S; Lam-Ubol A; Chotechuang N; Pongpirul W; Prasithsirikul W
    Int J Infect Dis; 2021 May; 106():329-337. PubMed ID: 33819604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity.
    Printza A; Katotomichelakis M; Valsamidis K; Metallidis S; Panagopoulos P; Panopoulou M; Petrakis V; Constantinidis J
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801170
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models.
    Butowt R; Meunier N; Bryche B; von Bartheld CS
    Acta Neuropathol; 2021 Jun; 141(6):809-822. PubMed ID: 33903954
    [TBL] [Abstract][Full Text] [Related]  

  • 67. COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts.
    Sehanobish E; Barbi M; Fong V; Kravitz M; Sanchez Tejera D; Asad M; Matsumura C; Ferastraoaru D; O'Neill M; Karagic M; Akbar N; Bottalico DM; Patel V; Peshansky A; Rangareddy M; Hudes G; Kim M; Eisenberg R; Nath A; Smith BR; Ow TJ; Jerschow E
    Am J Rhinol Allergy; 2021 Nov; 35(6):830-839. PubMed ID: 33813917
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.
    Singh J; Samal J; Kumar V; Sharma J; Agrawal U; Ehtesham NZ; Sundar D; Rahman SA; Hira S; Hasnain SE
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33803400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
    Zhao YH; Zhao L; Yang XC; Wang P
    Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Findings from the first public COVID-19 temporary test centre in Hong Kong.
    Leung WLH; Yu ELM; Wong SC; Leung M; Lee LLY; Chung KL; Cheng VCC
    Hong Kong Med J; 2021 Apr; 27(2):99-105. PubMed ID: 33790053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.
    Koyama S; Ueha R; Kondo K
    J Med Internet Res; 2021 Apr; 23(4):e26459. PubMed ID: 33788699
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 73. Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19.
    Saussez S; Hans S; Chiesa-Estomba CM; Lechien JR
    J Intern Med; 2021 Aug; 290(2):468-469. PubMed ID: 33817882
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Challenges of SARS-CoV-2 genomic surveillance in Africa.
    Adepoju P
    Lancet Microbe; 2021 Apr; 2(4):e139. PubMed ID: 33817677
    [No Abstract]   [Full Text] [Related]  

  • 75. The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials.
    Lin WT; Hung SH; Lai CC; Wang CY; Chen CH
    Int Immunopharmacol; 2021 Jul; 96():107602. PubMed ID: 33812260
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection.
    Donegani MI; Miceli A; Pardini M; Bauckneht M; Chiola S; Pennone M; Marini C; Massa F; Raffa S; Ferrarazzo G; Arnaldi D; Sambuceti G; Nobili F; Morbelli S
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33808956
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Hoffmann M; Arora P; Groß R; Seidel A; Hörnich BF; Hahn AS; Krüger N; Graichen L; Hofmann-Winkler H; Kempf A; Winkler MS; Schulz S; Jäck HM; Jahrsdörfer B; Schrezenmeier H; Müller M; Kleger A; Münch J; Pöhlmann S
    Cell; 2021 Apr; 184(9):2384-2393.e12. PubMed ID: 33794143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Longitudinal dynamics of antibody responses in recovered COVID-19 patients.
    Cheng ML; Liu HY; Zhao H; Wang GQ; Zhou C; Zheng J; Li XF; Li F; Bai CQ; Qin CF
    Signal Transduct Target Ther; 2021 Mar; 6(1):137. PubMed ID: 33790222
    [No Abstract]   [Full Text] [Related]  

  • 79. Convalescent Blood: Current Perspective on the Efficacy of a Legacy Approach in COVID-19 Treatment.
    Sheervalilou R; Shirvaliloo M; Sargazi S; Bahari S; Saravani R; Shahraki J; Shirvalilou S; Shahraki O; Nazarlou Z; Shams Z; Ghaznavi H
    Blood Purif; 2022; 51(1):1-14. PubMed ID: 33789273
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.